This Form 144 from Goldman Sachs reflects routine market-making activity, not a conviction-based insider sale. The filing is unlikely to move the stock. Monitor for any actual sales on Form 4 and watch for any change in the pattern of insider selling from directors or officers.
Price Chart
Executive Summary
Goldman Sachs Group Inc., a former 10% owner of Attovia Therapeutics, filed a Form 144 notice of intent to sell 105,807 shares of common stock, valued at approximately $2.22 million. The shares were acquired through securities borrowing by Goldman Sachs & Co. LLC acting as a market maker in the ordinary course of business. This filing is part of a broader insider selling cluster, including a director's sale, totaling $169K in the prior week, but the Goldman Sachs sale is a routine market-making activity, not a directional insider signal.
Key Facts
- Goldman Sachs Group Inc., a former 10% owner, filed Form 144 to sell 105,807 shares of ATTO common stock.
- The proposed sale value is approximately $2,221,947 based on a recent market price.
- Shares were acquired through securities borrowing by Goldman Sachs & Co. LLC acting as a market maker in the ordinary course of business.
- The filing date is August 28, 2026, with the sale date noted as August 5, 2026.
- A separate insider cluster from July 29 to August 5, 2026, showed $169K in total insider selling, including a director's sale of $154K.
Financial Impact
Proposed sale of 105,807 shares valued at ~$2.22M, representing approximately 0.25% of shares outstanding based on market cap of $978M.
Risk Factors
- The proposed sale may still be executed, adding modest selling pressure.
- The broader insider selling cluster, though small, could indicate reduced insider conviction.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (ATTO) — Batch item 1 | 0000891836-26-000065 |
| Document: 0000891836-26-000065-index.html | cluster-ATTO-1787954486593 |
| Document: 0000891836-26-000065.txt | 0000891836-26-000065 |
| 144 Filing (ATTO) — Batch item 4 | 0000891836-26-000065 |
| Document: 0000891836-26-000065-index.html | 0000891836-26-000065 |
| Document: 0000891836-26-000065.txt | 0000891836-26-000065 |
| CLUSTER Data (Synthetic) | 0000891836-26-000065 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 18d ago | 3/A | $16.21 | awaiting T+20 | — | $14.20 (−12.37%) |
Oct 8, 2026 18d ago | 3/A | $16.21 | awaiting T+20 | — | $14.20 (−12.37%) |
Sep 28, 2026 28d ago | Press Release | $18.16 | awaiting T+20 | — | $14.20 (−21.78%) |
Sep 2, 2026 7w ago | Press Release | $24.20 $17.14 | ▼ −29.17% | ▼ −28.06% | $14.20 (−41.30%) |
Aug 28, 2026 8w ago | 144 / CLUSTER | $21.40 $18.16 | ▼ −15.14% | ▼ −14.95% | $14.20 (−33.62%) |
Aug 13, 2026 10w ago | Insider Buy | $19.86 $24.52 | ▲ +23.46% | ▲ +25.46% | $14.20 (−28.47%) |
Aug 13, 2026 10w ago | Insider Cluster | $19.86 $24.52 | ▲ +23.46% | ▲ +25.46% | $14.20 (−28.47%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.65 $22.86 | ▲ +22.57% | ▲ +23.63% | $14.20 (−23.83%) |
Aug 7, 2026 11w ago | Insider Cluster | $19.84 $23.66 | ▲ +19.25% | ▲ +20.17% | $14.20 (−28.40%) |
Aug 7, 2026 11w ago | Insider Cluster | $20.17 $25.55 | ▲ +26.67% | ▲ +27.07% | $14.20 (−29.57%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers